It is expressed at low or undetectable levels in normal tissues, and overexpressed in cancers of pancreas, lung, colon, stomach, and soft tissue sarcomas.[19] In a study by Jiang et al.,[20] IMP-3 was overexpressed in 10% of stage-1 ccRCC. Here, IMP3 is linked to nonpapillary renal cell carcinoma.